Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
Cumberland Pharma (CPIX) Reports Q1 EPS of $0.02
May 10, 2016 4:28 PM EDTCumberland Pharma (NASDAQ: CPIX) reported Q1 EPS of $0.02, versus $0.09 reported last year. Revenue for the quarter came in at $7.7 million, versus $8.7 million reported last year.
For earnings history and earnings-related data on Cumberland Pharma (CPIX) click here.
... More